<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="ro">
	<id>https://wiki.tradeville.ro/index.php?action=history&amp;feed=atom&amp;title=Kymera_Therapeutics%2C_Inc.</id>
	<title>Kymera Therapeutics, Inc. - Revizia istoricului</title>
	<link rel="self" type="application/atom+xml" href="https://wiki.tradeville.ro/index.php?action=history&amp;feed=atom&amp;title=Kymera_Therapeutics%2C_Inc."/>
	<link rel="alternate" type="text/html" href="https://wiki.tradeville.ro/index.php?title=Kymera_Therapeutics,_Inc.&amp;action=history"/>
	<updated>2026-04-05T05:38:56Z</updated>
	<subtitle>Istoricul versiunilor pentru această pagină din wiki</subtitle>
	<generator>MediaWiki 1.39.2</generator>
	<entry>
		<id>https://wiki.tradeville.ro/index.php?title=Kymera_Therapeutics,_Inc.&amp;diff=427859&amp;oldid=prev</id>
		<title>Admin: Pagină nouă: Pagina dedicata companiei Kymera Therapeutics, Inc. listata cu simbolul US.KYMR  ==Descriere companie== Kymera Therapeutics, (www.kymeratx.com) Inc. is a biopharmaceutical company. The Company is focused on discovering and developing small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. Its targeted protein degradation platform, Pegasus, allows it to discover selective small molecule prot...</title>
		<link rel="alternate" type="text/html" href="https://wiki.tradeville.ro/index.php?title=Kymera_Therapeutics,_Inc.&amp;diff=427859&amp;oldid=prev"/>
		<updated>2024-09-18T18:08:34Z</updated>

		<summary type="html">&lt;p&gt;Pagină nouă: Pagina dedicata companiei Kymera Therapeutics, Inc. listata cu simbolul US.KYMR  ==Descriere companie== Kymera Therapeutics, (www.kymeratx.com) Inc. is a biopharmaceutical company. The Company is focused on discovering and developing small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body&amp;#039;s own natural protein degradation system. Its targeted protein degradation platform, Pegasus, allows it to discover selective small molecule prot...&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Pagină nouă&lt;/b&gt;&lt;/p&gt;&lt;div&gt;Pagina dedicata companiei Kymera Therapeutics, Inc. listata cu simbolul US.KYMR&lt;br /&gt;
&lt;br /&gt;
==Descriere companie==&lt;br /&gt;
Kymera Therapeutics, (www.kymeratx.com) Inc. is a biopharmaceutical company. The Company is focused on discovering and developing small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. Its targeted protein degradation platform, Pegasus, allows it to discover selective small molecule protein degraders with activity against disease-causing proteins throughout the body. Its Pegasus platform, includes E3 Ligase Whole-Body Atlas, E3 Ligase Binders Toolbox, Ternary Complex Modeling, Quantitative System Pharmacology Model and Proprietary Chemistry. Its therapeutic pipeline programs includes IRAK4, IRAKIMiD, and STAT3, which each focus on a single critical signaling node within the genetically and clinically validated interleukin-1 receptor/toll-like receptor ( IL-1R/TLR) and janus kinase/signal transducers and activators of transcription (JAK/STAT) pathways.&lt;br /&gt;
&lt;br /&gt;
==Grafic actiuni companie==&lt;br /&gt;
&amp;lt;iframe key=&amp;quot;tradeville&amp;quot; path=&amp;quot;graficSimbol/US.KYMR&amp;quot; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Ultimele stiri despre Kymera Therapeutics, Inc. (US.KYMR)==&lt;br /&gt;
&amp;lt;dynamicpagelist&amp;gt;&lt;br /&gt;
category=US.KYMR&lt;br /&gt;
count=10&lt;br /&gt;
order=descending&lt;br /&gt;
addfirstcategorydate=false&lt;br /&gt;
&amp;lt;/dynamicpagelist&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Categorie:US.KYMR]][[Categorie:Stiri despre companii]]&lt;/div&gt;</summary>
		<author><name>Admin</name></author>
	</entry>
</feed>